论文信息 - Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041) - 字舞流文

Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041)

M. Fujimoto | H. Ihn | H. Wada | H. Uchi | K. Yokota | N. Yamazaki | K. Nakagawa | H. Furukawa | H. Uhara | Y. Kiyohara | T. Inozume | T. Takenouchi | T. Shimamoto | K. Noguchi